The role of polysaccharides from natural resources to design oral insulin micro- and nanoparticles intended for the treatment of Diabetes mellitus: A review

Autor(es)

Meneguin, Andreia Bagliotti ^[1] ; Silvestre, Amanda Leticia Polli ^[1] ; Sposito, Larissa ^[1] ; de Souza, Mauricio Palmeira Chaves ^[1] ; Sabio, Rafael Miguel ^[1] ; Araujo, Victor Hugo Sousa ^[1] ; Cury, Beatriz Stringhetti Ferreira ^[1] ; Chorilli, Marlus ^[1]

Afiliação do(s) autor(es)

^[1] Sao Paulo State Univ, Sch Pharmaceut Sci, BR-14800903 Araraquara, SP - Brazil

• Tipo de documento: Artigo de Revisão
• Fonte: Carbohydrate Polymers; v. 256, MAR 15 2021.
• Citações Web of Science: 0

Resumo

Oral administration of insulin (INS) would represent a revolution in the treatment of diabetes, considering that this route mimics the physiological dynamics of endogenous INS. Nano- and microencapsulation exploiting the advantageous polysaccharides properties has been considered an important technological strategy to protect INS against harsh conditions of gastrointestinal tract, in the same time that improve the permeability via transcellular and/or paracellular pathways, safety and in some cases even selectivity for targeting delivery of INS. In fact, some polysaccharides also give to the systems functional properties such as pH-responsiveness, mucoadhesiveness under specific physiological conditions and increased intestinal permeability. In general, all polysaccharides can be functionalized with specific molecules becoming more selective to the cells to which INS is delivered. The present review highlights the advances in the past 10 years on micro- and nanoencapsulation of INS exploiting the unique natural properties of polysaccharides, including chitosan, starch, alginate, pectin, and dextran, among others. (AU)

• Processo FAPESP: 19/09597-6 - Micropartículas gastrorretentivas contendo nanopartículas de trans resveratrol aplicadas ao tratamento de infecções por Helicobacter pylori
• Beneficiário: Larissa Sposito
• Modalidade de apoio: Bolsas no Brasil - Doutorado
• Processo FAPESP: 14/50928-2 - INCT 2014: Nanotecnologia Farmacêutica: uma abordagem transdisciplinar
• Beneficiário: Maria Vitória Lopes Badra Bentley
• Modalidade de apoio: Auxílio à Pesquisa - Temático
• Processo FAPESP: 19/19817-3 - Sistemas biorresponsivos baseados em amido retrogradado/pectina acrescidos de nanofibras de celulose como estratégia para liberação colônica do 5-ASA no tratamento da Doença Inflamatória Intestinal
• Beneficiário: Andréia Bagliotti Meneguin
• Modalidade de apoio: Bolsas no Brasil - Pós-Doutorado